U.S. INTRAVENOUS SOLUTIONS MARKET ANALYSIS

U.S. Intravenous Solutions Market, By Solution Type (Saline(Normal Saline (0.9% NaCl), Hypertonic Solution), Dextran (D5W 5% dextrose in water, Analog Hypertonic Saline), Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and trace elements, Mixed Solutions), By Packaging (Ampules, Vials, Cartridges, Bottles, Bags (Large Volume Bags (greater than 250ml), Small Volume Bags (less than 250ml)), By Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, Irrigation IV Solution), By End User (Hospital, Clinics, Ambulatory Surgical Centers, Home Care Settings, Others)

Published In : Sep 2023
Code : CMI3400
Pages :120
Formats :
Excel and PDF
Industry : Pharmaceutical

U.S. Intravenous Solutions MarketSize and Trends

The U.S intravenous solutions market is estimated to be valued at US$ 3,171.1 Mn in 2023 and is expected to exhibit a CAGR of 7.2% during the forecast period (2023-2030).

U.S Intravenous Solutions Market - Key Trends

U.S Intravenous Solutions Market: Key Trends

Introduction of systems with advanced technology for IV insertion: The introduction of systems with advanced technology for IV insertion in the market is expected to drive growth of the U.S. intravenous solutions market over the forecast period.

Market Size in 2023: US$ 3,171.1 Mn

Forecast Period: 2023 to 2030 Forecast Period 2023 to 2030 CAGR: 7.2% 2030 Value Projection: US$ 5,165.3 Mn